Introduction 45
Antibiotic resistance in bacteria continues to be a serious problem. The number of 46 antibiotic-resistant pathogens is increasing, the level of resistance to standard antibiotics is 47 amphipathic. Previous investigations suggest that a repeated peptide motif with one cationic 69 residue followed by either one or two hydrophobic residues may be an important feature for 70 efficient membrane penetration (39). More recently, we have compared a variety of 71 membrane-penetrating peptides for their abilities to enhance the efficacy of peptide-72 phosphorodiamidate morpholino oligomers (PPMO), and found differences among peptides 73 that vary in their pattern of alternating cationic and nonpolar residues and their amino acid 74 compositions (27) . 75 Despite the progress that has been made on improving efficacy and potency of 76 antisense oligomers, little is known about bacterial resistance to these compounds. Some 77 naturally-occurring antimicrobial peptides, which have some similar characteristics to the 78 synthetic peptides used to make peptide-oligomers, do not appear to cause resistance in 79 bacteria (38) . One report of resistance to an antisense morpholino oligomer found a mutation 80 in the region of a virus genome targeted by the oligomer (28). Resistance to any antibiotic is 81 a guanine in the Luc PPMO was necessary to make the oligomer soluble in aqueous solutions 114 by avoiding guanine quartet structure. The scrambled base sequence control (Scr) is 5'-115 TCTCAGATGGT-3'. 116
Antibiotics. Antibiotics were purchased from Sigma-Aldrich, except bleomycin (Enzo 117
Life Science, Farmingdale, NY). 118
Minimal inhibitory concentration. Minimal inhibitory concentration was determined 119
by the microdilution method (5) in Mueller-Hinton II broth. For MICs using XL1-Blue MRF' and 120 RR3, Mueller-Hinton II broth was supplemented with 1% tryptone. 121
Luciferase expression. Spontaneous (RFF) 3 RXB-AcpP-resistant mutants were made 122 chemically competent and transformed as described (29) with pSE380myc-Luc (11). 123
Overnight cultures were grown aerobically at 37°C in LB medium plus 50 µg/ml ampicillin 124 (LBA), and then diluted 2 x 10 -2 into LBA with or without various concentrations (8, 20 and 50 125 μM) of (RFF) 3 RXB-Luc or (RFF) 3 RXB-Scr, and grown aerobically at 37°C for 7 h. Samples 126 were analyzed for luciferase expression by luminometry as described (11). 127 7 PBS + 15% glycerol at -75°C. The pooled transductants were thawed and 1 x 10 4 cfu was 137 spread on an LB plate that included 20 μM (RFF) 3 RXB-AcpP. Insertion mutations from 138 PPMO-resistant mutants were sequenced by rescue cloning as described by the 139 manufacturer (Epicentre). Insertions in sbmA were confirmed using polymerase chain 140 reaction (PCR) as described (18). Briefly, PCR reactions contained chromosomal DNA 141 extracted from bacteria using a commercial kit (DNAeasy, Qiagen, Valenica, CA) and primers 142 TAACGCCTGGTGGCCGTTGATG-3'. The PCR products were gel-purified using Qiagen 151
MinElute PCR purification kit (Valencia, CA), and sequenced using the same primers shown 152 above at the core laboratory of the Center for Genome Research, Oregon State University. 153
Genomic sequencing. Genomic DNA from the W3110 wild type and PR200.1 was 154 generated by standard procedures (1). DNA was sheared by sonication and processed for 155
Illumina high-throughput sequencing as previously described (31, 32). Data analyses to find 156 individual point mutations were carried out as described (32). 157
158

Results
160
Spontaneous mutants resistant to peptide-PMO. Spontaneous resistance was 161 apparent from growth that occasionally occurred in some cultures that included (RFF) 3 
RXB-162
AcpP (X is 6-aminohexanoic acid and B is β-alanine) at concentrations above the MIC. 163
Growth above the MIC was never observed in cultures that included other AcpP PPMOs with 164 different peptides attached to the same PMO, such as (RX) 6 B-AcpP or (RXR) 4 XB-AcpP. The 165 rate of spontaneous resistance to (RFF) 3 RXB-AcpP was measured and found to be 4  10 -7 166 mutations/cell generation. 167
Susceptibility to antibiotics and growth rate. Colonies were isolated from a single 168 liquid culture of W3110 grown with 8 × MIC (20 μM = 112 μg/ml) of (RFF) 3 RXB-AcpP. One 169 colony (PR200.1) was picked at random and further characterized. PR200.1 was equally 170 susceptible as the parent strain W3110 to each antibiotic tested (MIC = 4 µg/ml, 1.25 µg/ml, 171 1.25 µg/ml, 0.125 µg/ml, and 10 µg/ml for ampicillin, tetracycline, kanamycin, polymyxin B, 172 and rifampin, respectively). These results indicate that this particular PPMO-resistant isolate 173
was not resistant to antibiotics in general. 174 Doubling times of PR200.1 and W3110 were identical and no difference in growth rate 175 was observed in liquid or solid media. The results show that PR200.1 was resistant to every AcpP PMO tested with the C-N-194 N peptide motif, but was fully susceptible to (RX) 6 B-AcpP PMO and (RXR) 4 XB-AcpP PMO 195 (Table 1) . However, PR200. W3110 showed inhibition of luciferase that was proportional to the concentration of PPMO 220 added. The scrambled sequence control did not inhibit luciferase in either strain. There were 221 no differences in the growth (optical density) of any of the cultures (data not shown). 222
Peptide transport mutants. The above results indicated that resistance to PPMOs is 223
linked to the peptide moiety. We hypothesized that PPMO-resistance could be caused by a 224 mutation in one of three known oligopeptide transporters. To test this, the MIC was measured 225 using various strains with mutations in one, two, or all three oligopeptide transporters (Table11 2). The results show that (RFF) 3 RXB-AcpP had the same MIC in PR200.1 as the parent 227 (non-mutant) strain. (RFF) 3 RXB-Scr scrambled control showed no detectable MIC (>160 μM). 228
Genomic sequencing. The genomes of PR200.1 and its parent strain W3110 were 229 sequence and compared. The results indicated that a total of 3 genes had mutations in 230 PR200.1 compared to W3110: dctA, eptA, and sbmA. In dctA, there were 2 transition 231 mutations at bases 3958154 (T→A) and 395153 (A→G), both of which are in codon 396, that 232 caused a missense from ile to ala. In eptA, there was one transversion mutation at base 233 4339795 (T→A) that affected codon 259 and caused a missense from ser to thr. In sbmA, 234 there was one transversion mutation at base 396121 (T→G) that changed codon 87 (ser to 235 ala). No deletions or insertions were detected in any gene. 236
Characterize deletion mutants. In frame knock-out mutants of dctA, eptA, and sbmA 237 were tested for susceptibility to (RFF) 3 RXB-AcpP and compared to the parent strain 238 (BW25113). The MIC of (RFF) 3 RXB-AcpP was the same (2 μM = 11 μg/ml) using either the 239 dctA -or eptA -knock-out strains or the parent strain. The MIC using the sbmA -strain was 32 240 μM (179 μg/ml). 241
The MIC of (RXR) 4 XB-AcpP was measured using sbmA -strain as indicator, and found 242 to be 2 μM (11 μg/ml), the same as its isogenic parent strain.
transposome EZ-Tn5 and a library of 1 x 10 4 mutants was spread on selection plates that 250 included 20 μM (RFF) 3 R-AcpP. Two colonies grew on the selection plate, and the mutated 251 gene in each was sequenced. The sequences of both isolates indicated that the transposome 252 had inserted into the exact same position in sbmA in each isolate, suggesting that the two 253 colonies were clones. The isolates were named RR3. 254 RR3 was characterized by measuring the MICs of various standard antibiotics (Table  255 3). All standard antibiotics tested had the same MIC using either XL1-Blue MRF' or RR3 as 256 indicator, including two peptide antibiotics colistin and polymyxin B. However, RR3 was about 257 4-fold resistant to each of the peptide antibiotics bleomycin and phleomycin. PR200. The MICs of (RFF) 3 R-AcpP and (RXR) 4 XB-AcpP were measured using RR3 or XL1-262
Blue MRF' as indicators. The results show that RR3 was 32-fold resistant to (RFF) 3 
RXB-263
AcpP, and 8-fold resistant to (RXR) 4 XB-AcpP (Table 3) RR3 and XL1-Blue MRF' were genetically complemented with pSbmA and used to 267 measure the MIC of (RFF) 3 RXB-AcpP. pSbma fully restored susceptibility of RR3 to the 268 PPMO, when induced with IPTG (Table 3) . Interestingly, the MIC was significantly less using 269 the complemented strains as indicators compared to the strains without pSbmA.
Discussion 273
This is the first report we are aware of to characterize bacterial resistance to an 274 antisense antibacterial compound. Initially, growth was occasionally and unexpectedly 275 observed during routine MIC assays of (RFF) 3 XB-AcpP in cultures 4-to 8-fold above the MIC. 276
Similar growth was never observed during MIC assays for (RXR) 4 XB-AcpP or (RX) 6 B-AcpP. 277
We speculate that the greater number of X residues (6-aminohexanoic acid) or the lack of F in 278 the latter two PPMOs may be responsible for the apparent lack of spontaneous resistance to 279 these PPMOs under the conditions used for the MIC assay. Alternatively, there could be 280 more genetic loci involved in resistance to (RFF) 3 RXB PPMOs than in any (putative) 281 resistance to PPMOs conjugated to other peptides such as (RXR) 4 XB or (RX) 6 B. However, 282
we have not yet rigorously pursued resistance to these later PPMOs, and it is certainly 283 possible that spontaneous resistance may occur under appropriate conditions. 284
The rate of spontaneous resistance to (RFF) 3 RXB-AcpP was similar to the rate of 285 spontaneous mutation for individual genes in E. coli, which is typically between 10 -6 to 10 -7 286 mutations/gene/ generation (6, 24). This suggests that there are few genes which, when 287 mutated, can give rise to the PPMO-resistant phenotype. However, the rate of mutation can 288 vary widely, and any measurement of the rate of mutation is a function of many variables (25), 289 including the concentration of antibiotic used for selection, and the number of genes or loci 290 capable of causing a resistance phenotype. Ultimately, the rate of resistance to PPMOs 291 under in vivo conditions for specific infections will be the most meaningful measure of their 292 usefulness in the clinic.
14 The spontaneous mutant PR200.1 was susceptible to all small molecule antibiotics 294 tested. This shows that resistance to the PPMO is not caused by a change in physiology that 295 might result in resistance to antibiotics in general. Such general changes are known to occur, 296 and include a reduction of the net negative charge of the lipopolysaccharide of Gram-negative 297 bacteria (7, 30), changes in capsule polysaccharide (4), changes in expression of outer 298 membrane porins (30), alterations in outer membrane lipid composition that results in 299 decreased membrane permeability (30), and activation or overexpression of multidrug efflux 300 pumps (21). We tested a variety of antibiotics, some of which are hydrophilic (ampicillin, 301 kanamycin), hydrophobic (rifampin, tetracycline), or amphiphilic (polymyxin B), and some 302 which enter Gram-negative bacteria through the outer membrane porins (ampicillin, 303 tetracycline) or through the outer membrane lipid bilayer (rifampin, polymyxin B). The results 304 suggested that the mutation in PR200.1 is specific for (RFF) 3 RXB-AcpP or PPMOs with 305 similar peptide moieties. Later, following the identification of the mutation in sbmA, PR200.1 306 was found to be mildly resistant (4-fold) to the peptide antibiotics bleomycin and phleomycin. 307
We hypothesized that resistance was caused by a mutation in the sequence of acpP 308 targeted by the PPMO. We have previously shown that a one-base mismatch near the 3'end 309 of a PPMO targeted to acpP in Burkholderia cepacia complex raised the MIC by a factor of at 310 least 8-32-fold (15). However, the results in the present report found no mutation in the target 311 region of acpP in this one resistant mutant. Therefore, the hypothesis in this case was 312 disproven. However, this is not to say that target site mutations cannot or do not occur on 313 other as of yet uncharacterized mutants. Nevertheless, target site mutations would be 314 statistically improbable considering that there are only 4 wobble bases in the target region ofsequence of the targeted protein. 317 Another hypothesis was that resistance in PR200.1 was caused by a mutation in an 318 oligopeptide transporter. However, oligopeptide transport mutants were just as susceptible to 319 (RFF) 3 RXB-AcpP as the isogenic parent strain. This showed that resistance in PR200.1 was 320 not caused by a mutation in the known oligopeptide transporters that were tested. 321
In another effort to identify the mutation in PR200.1 that is responsible for resistance to 322 (RFF) 3 RXB-AcpP, the genome of PR200.1 was sequenced. The results showed missense 323 mutations in only 3 genes compared to the PPMO-susceptible strain: dctA, eptA, and sbmA. 324
In-frame, non-polar deletion mutations of each gene showed that of the three, only the sbmA 325 deletion strain was resistant to (RFF) 3 RXB-AcpP. Furthermore, complementation of PR200.1 326 with sbmA restored susceptibility to the PPMO. These results show that mutations in sbmA 327 cause resistance to (RFF) 3 RXB-AcpP. 328
The MIC of (RFF) 3 RXB-AcpP was slightly lower using the sbmA deletion strain than 329 PR200.1 as indicator. However, the strains originated from different parent strains, and this 330 probably accounts for the difference in susceptibility. The parent strain of the sbmA deletion 331 was also slightly more susceptible to the PPMO than the parent strain of PR200.1. 332
The transposome mutant RR3 was resistant to both (RFF) 3 RXB-AcpP and (RXR) 4 XB-333
AcpP. This differs from the spontaneous mutant PR200.1 and the sbmA deletion strain, 334 which were resistant to (RFF) 3 RXB-AcpP but not (RXR) 4 XB-AcpP. This suggests that a polar 335 affect in RR3 on the gene downstream from sbmA (yaiW) may be responsible for resistance 336 to (RXR) 4 XB-AcpP. yaiW is a predicted DNA-binding transcriptional regulator. Apparently a 337 mutation in sbmA is sufficient to cause resistance to (RFF) 3 RXB-AcpP, but not (RXR) 4 -AcpP.these two PPMOs share the same C-N-C repeat motif. This indicates that the amino acid 340 composition of the PPMOs may be more important than the repeating pattern of amino acids 341 in determining resistance in PR200.1. The similarity in resistance of PR200.1 to either 342 (RFF) 3 RXB-AcpP or (RFR) 4 XB-AcpP, but complete susceptibility to (RXR) 4 XB-AcpP may 343
suggest that X (6-aminohexanoic acid) accounts for the difference. This is supported by the 344 result ( Table 1) of sbmA in Rhizobium meliloti, bacA, is required for symbiosis with alfalfa (9). The homolog inmolecules (43). Development of an assay to measure uptake of PPMOs is currently not 361 available, but could be used to define further the role of SbmA in resistance to PPMO. 362
The substrate specificity of SbmA has been investigated and found to be quite flexible. 363
Initially, the specificity was proposed to be associated with a thiazole or oxazole structural 364 motif (43). Later, proline-rich antimicrobial peptides were shown to be transported by SbmA 365 (26). However, (RFF) 3 RXB-AcpP has none of these structural features. If SbmA is the 366 transporter of (RFF) 3 RXB-AcpP, apparently the specificity of SbmA is not limited to thiazole-367 or oxazole-containing compounds or to proline-rich peptides. Our results suggest that the 368 substrate specificity of SbmA is flexible enough to accommodate polypeptides without 369 thiazole, oxazole, or proline. With the peptides we used in our conjugates, the specificity 370 appears to be linked to the spacing of cationic and non-polar amino acid residues within the 371 context of the peptide. It is also noteworthy that our all-D enantiomer conjugate (NG-05-0653) 372 had the same MIC values as the all-L conjugate (NG-05-0200) for parental and resistant 373 strains. This is in contrast to results shown for an all-D isomer of the proline-rich antimicrobial 374 peptide Bac7(1-35), which was ineffective compared to the all-L form (26). It was suggested 375 that the stereospecificity of Bac7(1-35) was attributable to its interaction with SbmA, although 376 uptake of all-D Bac7(1-35) was not demonstrated. Perhaps the stereospecificity of Bac7 (1-35) 377 is caused by its interaction with its cytoplasmic target and not SbmA. Our results suggest that 378 the specificity of SbmA is not necessarily limited to either the L-or D-enantiomeric form of a 379 peptide, and is broader than previously known. 380
If SbmA is the plasma membrane transporter for (RFF) 3 R-AcpP, we speculate that 381 other mechanisms exist for PPMOs to cross the plasma membrane. PR200.1, RR3, and theconcentrations. We speculate that PPMOs may be able to cross the plasma membrane by 384 passing through the lipid bilayer in the same manner that they cross the outer membrane. 385
There also may be additional active transporters with specificities for nucleic acid oligomers. 386
This latter possibility is suggested by the ability of PMOs (not conjugated to a peptide) to 387 inhibit gene expression in strains with porous outer membranes that allow passage of large 388 oligomers (11, 12). 389
In summary, the results suggest that bacterial resistance to a PPMO can be 390 Scr]. After 7 h samples of each culture were measured for luciferase activity by luminometry. 579
The experiment was repeated 3 times and the error bars indicate standard deviation. 580 *indicates a highly significant (P < 0.01) difference compared to cultures of PR200.1 with the 581 same concentrations of (RFF) 3 RXB-Luc, the cultures of W3110 with the same concentrations [111] *X is 6-amino-hexanoic acid. B is β-alanine. O is ornithine. D indicates the isomeric form or the residue that follows. **Motif 1 is (cationic-nonpolar-nonpolar, abbreviated C-N-N). Motif 2 is (cationicnonpolar, abbreviated C-N). Motif 3 is (cationic-nonpolar-cationic, abbreviated C-N-C). 
